Lysosomal Membrane Protein SCARB2 Mediates the Pathogenesis of Diabetic Retinopathy Through the MAPK / ERK / MMP9 Signaling Pathway
The FASEB Journal · 2026
DOI: 10.1096/fj.202601737r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2026. Verfasst von Jiawei Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Lysosomal Membrane Proteins, Matrix Metalloproteinase 9, MAP Kinase Signaling System. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), | Science Fund for Distinguished Young Scholars of Anhui Province (), National Natural Science Foundation of China.
Abstract (Originalsprache)
Diabetic retinopathy (DR), the most prevalent complication of diabetes, remains a major cause of preventable blindness in the working‐age population. Retinal microvascular endothelial cell dysfunction is central to DR pathogenesis, and lysosomal pathways play a key role in regulating endothelial injury. This study aims to identify potential core regulators of endothelial dysfunction in DR and explore their regulatory mechanisms, thereby providing therapeutic targets for DR treatment. Transcriptome sequencing was first performed to screen for potential core regulators associated with endothelial dysfunction in DR. Scavenger receptor class B member 2 (SCARB2) was identified as a candidate. Two experimental models were constructed for validation: a HG‐stimulated retinal microvascular endothelial cell model and a STZ‐induced diabetic rat model. Western blot, tube formation assay, Transwell, EdU proliferation assay, immunofluorescence, and Evans Blue assay were conducted to evaluate the effect of SCARB2 on endothelial dysfunction. RNA‐seq analysis was further used to explore the downstream signaling pathway of SCARB2. Transcriptome sequencing confirmed SCARB2 as a potential core regulator of endothelial dysfunction in DR. Under high‐glucose conditions, elevated SCARB2 exacerbates retinal microvascular endothelial cell injury and promotes neovascularization and DR progression by upregulating VEGFR1 and VEGFA. Mechanistically, SCARB2 modulates MMP9 via the MAPK/ERK pathway, mediates endothelial cell migration and invasion, and facilitates pathological neovascularization. SCARB2 is a key regulator in the progression of diabetic retinopathy, which modulates endothelial dysfunction by regulating the MAPK/ERK/MMP9 signaling pathway. This study identifies SCARB2 as a novel potential therapeutic target for the treatment of diabetic retinopathy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, The Second Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
ORCID-Profile: Zhengxuan Jiang
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- | Science Fund for Distinguished Young Scholars of Anhui Province ()
- National Natural Science Foundation of China
- Science Fund for Distinguished Young Scholars of Anhui Province
Zitieren
APA
Fan, J., Cao, W., Wang, J., Hao, Y., Zhang, F., Tao, Y., Gao, X., & Jiang, Z. (2026). Lysosomal Membrane Protein SCARB2 Mediates the Pathogenesis of Diabetic Retinopathy Through the MAPK / ERK / MMP9 Signaling Pathway. The FASEB Journal. https://doi.org/10.1096/fj.202601737r
Vancouver
Fan J, Cao W, Wang J, Hao Y, Zhang F, Tao Y, et al. Lysosomal Membrane Protein SCARB2 Mediates the Pathogenesis of Diabetic Retinopathy Through the MAPK / ERK / MMP9 Signaling Pathway. The FASEB Journal. 2026. doi:10.1096/fj.202601737r
BibTeX
@article{Fan2026,
author = {Fan, Jiawei and Cao, Weiqian and Wang, Jianghui and Hao, Yue and Zhang, Fangpu and Tao, Yulin and Gao, Xiang and Jiang, Zhengxuan},
title = {Lysosomal Membrane Protein SCARB2 Mediates the Pathogenesis of Diabetic Retinopathy Through the MAPK / ERK / MMP9 Signaling Pathway},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202601737r}
}
EUVIMED